SCA Pharmaceuticals Vancomycin HCl IV Solution Recall: Particulate Matter Hazard
SCA Pharmaceuticals recalls vancomycin HCl 750mg IV solution (NDC 70004-0929-40) due to particulate matter risk. This affects patients receiving IV treatment. Contact your healthcare provider for guidance.
Stop using this now
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Contact the company
What happened, in plain English
SCA Pharmaceuticals is recalling vancomycin HCl 750 mg IV solutions that may contain particulate matter. This could cause serious complications if injected into the bloodstream. Read more at govinfonow.com/recall/42049-sca-pharmaceuticals-vancomycin-hcl-iv-solution-recall-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/42049-sca-pharmaceuticals-vancomycin-hcl-iv-solution-recall-particulate-matter-hazard · Updated October 8, 2026 · FDA enforcement record: FDA #D-0644-2017
Cite this page
“SCA Pharmaceuticals Vancomycin HCl IV Solution Recall: Particulate Matter Hazard.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42049-sca-pharmaceuticals-vancomycin-hcl-iv-solution-recall-particulate-matter-hazard. Based on FDA recall #D-0644-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0644-2017%22&limit=1).
Why it’s dangerous
Particulate matter in the solution can enter the bloodstream during IV administration, potentially causing serious complications like infections or blockages. This recall follows a previous Hospira recall of similar vancomycin products.
Who’s affected
Patients receiving IV vancomycin treatment from this specific product. Healthcare providers using this solution for medical purposes are most at risk.
How to tell if you have this one
Check for the product name 'Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use Only'. The NDC code is 70004-0929-40 with lot number 20161222@8 and expiration date 2/5/2017.
- Brand
SCA Pharmaceuticals- Category
Drug
All 7 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
U.S. Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0639-2017 | Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0922-40; Lot: 20161221@70, Exp 02/04/2017 | 50 bags |
| D-0640-2017 | Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0920-59; Lot: 20161228@65, Exp 02/26/2017; Lot: 20161214@76, Exp 02/12/2017 | 386 bags |
| D-0641-2017 | Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0923-59; Lot: 20161213@23, Exp 2/11/2017; Lot: 20161214@80, Exp 2/12/2017; Lot: 20161215@1, Exp 2/13/2017 | 716 bags |
| D-0642-2017 | Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0924-59; Lot: 20161212@44, Exp 2/10/2017; Lot: 20161230@40, Exp 2/28/2017 | 490 bags |
| D-0643-2017 | Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume 515 mL For IV Use Only, Rx Only , SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0925-44; Lot: 20161221@74, Exp 2/4/2017 | 50 bags |
| D-0644-2017 | Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0929-40; Lot: 20161222@8, Exp 2/5/2017 | 30 bags |
| D-0645-2017 | Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0918-40; Lot: 20161219@3, Exp 2/2/2017 | 62 bags |
What to do — step by step
Stop Using Now
Immediately stop using this vancomycin solution if you have it. Do not administer it to patients.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0644-2017 (February 3, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0644-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.